Search Results

Business

Partek and Agilent Partner to Deliver Alissa Customers End-to-End Bioinformatics Workflow

Partek ® Incorporated announced today they have entered into an agreement with Agilent to integrate Partek ® Flow ® bioinformatics software with the Agilent Alissa Clinical Informatics Platform.

August 19, 2021

·

2 min read

Press Releases

Axxam S.p.A. accelerates global expansion incorporating Axxam Inc.

December 13, 2024

·

2 min read

Press Releases

Hemostemix Announces the Incorporation of Hemostemix PR Inc: 50% Reimbursement of R&D Expenses in Cash

January 6, 2025

·

9 min read

Press Releases

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates

November 6, 2024

·

8 min read

BioMidwest

Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Accuray Incorporated announced its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference taking place March 12-13, 2024.

February 27, 2024

·

1 min read

Press Releases

Medeologix Expands Hydrophilic Coating Services, Partners with Biocoat® Incorporated to Solidify Position as The Bay Area’s Premier Catheter Solutions Provider

November 6, 2024

·

3 min read

Press Releases

Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter Coating

August 28, 2024

·

2 min read

BioMidwest

Partek Genomic Analysis Software Reaches New Citation High: Over 8,000 Peer-Reviewed Articles

Partek Incorporated announced today that its software has been cited in over eight thousand peer-reviewed articles published in scientific journals, including the prestigious PNAS , Cell , and Nature Medicine journals. Topics throughout their twenty-seven-year history

October 15, 2020

·

2 min read

Press Releases

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

November 21, 2024

·

4 min read

Pharm Country

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned Share Dividend/Royalty Coupon

NRx Pharmaceuticals, Inc. announced the incorporation of HOPE Therapeutics™, a biotechnology company dedicated to bringing NRX-100, which will be re-designated HTX-100, a potentially lifesaving treatment option for patients with Suicidal Depression.

February 5, 2024

·

5 min read